Status:
COMPLETED
Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19
Lead Sponsor:
University of Alberta
Conditions:
Covid19
Dyspnea
Eligibility:
All Genders
18-70 years
Brief Summary
A novel corona virus emerged in 2019 causing Corona Virus Disease 2019 (covid-19). In one year more than 80 000 000 cases worldwide were documented. Some patients experience symptoms, specifically sho...
Detailed Description
Purpose and Justification: In less than one year, the novel coronavirus has infected more than 80 000 000 people worldwide. Infection causes Corona Virus Disease 2019 (covid-19) and in some cases sev...
Eligibility Criteria
Inclusion
- Covid-19/Symptom status as defined under each group.
Exclusion
- Previous diagnosis of pulmonary hypertension
- Obesity (body mass index \>30 kg/m2)
- Absolute contraindication to exercise testing or an orthopedic limitation that may interfere with cardiopulmonary exercise testing
Key Trial Info
Start Date :
March 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04732663
Start Date
March 4 2021
End Date
May 6 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Physiology Laboratory
Edmonton, Alberta, Canada, T6G2R3